Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
Upstream (Parents) |
---|
(<<) HLA-DRA → LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
(<<) IFI16 → LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
(<<) HLA-DRB1 → LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 |
Downstream (Children) |
---|
LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 → HLA-DOB (>>) |
LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 → C11orf63 (>>) |
LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 → HLA-DQA2///HLA-DQA1 (>>) |
LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 → HLA-DQB2 (>>) |
LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 → HLA-DRB1 (>>) |
LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 → HLA-F (>>) |